United Therapeutics Statistics
Total Valuation
UTHR has a market cap or net worth of $21.43 billion. The enterprise value is $17.63 billion.
| Market Cap | 21.43B |
| Enterprise Value | 17.63B |
Important Dates
The last earnings date was Wednesday, August 5, 2026, before market open.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
UTHR has 42.89 million shares outstanding. The number of shares has decreased by -3.20% in one year.
| Current Share Class | 42.89M |
| Shares Outstanding | 42.89M |
| Shares Change (YoY) | -3.20% |
| Shares Change (QoQ) | -2.97% |
| Owned by Insiders (%) | 1.95% |
| Owned by Institutions (%) | 93.54% |
| Float | 39.36M |
Valuation Ratios
The trailing PE ratio is 17.88 and the forward PE ratio is 19.19. UTHR's PEG ratio is 2.54.
| PE Ratio | 17.88 |
| Forward PE | 19.19 |
| PS Ratio | 6.79 |
| Forward PS | 6.91 |
| PB Ratio | 3.33 |
| P/TBV Ratio | 3.41 |
| P/FCF Ratio | 19.61 |
| P/OCF Ratio | 12.72 |
| PEG Ratio | 2.54 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.78, with an EV/FCF ratio of 16.13.
| EV / Earnings | 13.45 |
| EV / Sales | 5.59 |
| EV / EBITDA | 11.78 |
| EV / EBIT | 12.55 |
| EV / FCF | 16.13 |
Financial Position
The company has a current ratio of 5.73
| Current Ratio | 5.73 |
| Quick Ratio | 4.89 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 117.06 |
Financial Efficiency
Return on equity (ROE) is 19.32% and return on invested capital (ROIC) is 31.28%.
| Return on Equity (ROE) | 19.32% |
| Return on Assets (ROA) | 11.61% |
| Return on Invested Capital (ROIC) | 31.28% |
| Return on Capital Employed (ROCE) | 21.24% |
| Weighted Average Cost of Capital (WACC) | 7.35% |
| Revenue Per Employee | $2.25M |
| Profits Per Employee | $936,357 |
| Employee Count | 1,400 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 2.41 |
Taxes
In the past 12 months, UTHR has paid $262.10 million in taxes.
| Income Tax | 262.10M |
| Effective Tax Rate | 16.66% |
Stock Price Statistics
The stock price has increased by +61.35% in the last 52 weeks. The beta is 0.56, so UTHR's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | +61.35% |
| 50-Day Moving Average | 536.05 |
| 200-Day Moving Average | 518.94 |
| Relative Strength Index (RSI) | 32.89 |
| Average Volume (20 Days) | 521,022 |
Short Selling Information
The latest short interest is 2.32 million, so 5.42% of the outstanding shares have been sold short.
| Short Interest | 2.32M |
| Short Previous Month | 2.09M |
| Short % of Shares Out | 5.42% |
| Short % of Float | 5.90% |
| Short Ratio (days to cover) | 3.81 |
Income Statement
In the last 12 months, UTHR had revenue of $3.15 billion and earned $1.31 billion in profits. Earnings per share was $27.95.
| Revenue | 3.15B |
| Gross Profit | 2.72B |
| Operating Income | 1.40B |
| Pretax Income | 1.57B |
| Net Income | 1.31B |
| EBITDA | 1.50B |
| EBIT | 1.40B |
| Earnings Per Share (EPS) | $27.95 |
Balance Sheet
The company has $2.66 billion in cash and no debt, with a net cash position of $3.80 billion or $88.68 per share.
| Cash & Cash Equivalents | 2.66B |
| Total Debt | n/a |
| Net Cash | 3.80B |
| Net Cash Per Share | $88.68 |
| Equity (Book Value) | 6.40B |
| Book Value Per Share | 149.97 |
| Working Capital | 2.88B |
Cash Flow
In the last 12 months, operating cash flow was $1.69 billion and capital expenditures -$592.20 million, giving a free cash flow of $1.09 billion.
| Operating Cash Flow | 1.69B |
| Capital Expenditures | -592.20M |
| Depreciation & Amortization | 91.50M |
| Net Borrowing | n/a |
| Free Cash Flow | 1.09B |
| FCF Per Share | $25.48 |
Margins
Gross margin is 86.14%, with operating and profit margins of 44.53% and 41.56%.
| Gross Margin | 86.14% |
| Operating Margin | 44.53% |
| Pretax Margin | 49.87% |
| Profit Margin | 41.56% |
| EBITDA Margin | 47.43% |
| EBIT Margin | 44.53% |
| FCF Margin | 34.65% |
Dividends & Yields
UTHR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.20% |
| Shareholder Yield | 3.20% |
| Earnings Yield | 6.12% |
| FCF Yield | 5.10% |
Analyst Forecast
The average price target for UTHR is $653.23, which is 30.72% higher than the current price. The consensus rating is "Buy".
| Price Target | $653.23 |
| Price Target Difference | 30.72% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 7.63% |
| EPS Growth Forecast (3Y) | 10.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 23, 2009. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 23, 2009 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
UTHR has an Altman Z-Score of 18.19 and a Piotroski F-Score of 4.
| Altman Z-Score | 18.19 |
| Piotroski F-Score | 4 |